FierceBiotechAveXis SMA gene therapy advances toward pivotal trialFierceBiotechAveXis has posted top-line data from a phase 1 trial of its gene therapy against spinal muscular atrophy (SMA). All 15 patients were event-free at 13.6 months of age, a sign… Continue reading
PharmaTimes |
Myeloma UK launches ‘world first’ immunotherapy trial
PharmaTimes Myeloma UK has launched a ground-breaking immunotherapy trial which aims to modulate the immune system to target myeloma. In what the charity describes as a “world first”, the Phase Ib study, called MUK eleven, will investigate Oncolytics Biotech’ … |
PharmaTimes |
Myeloma UK launches ‘world first’ immunotherapy trial
PharmaTimes Myeloma UK has launched a ground-breaking immunotherapy trial which aims to modulate the immune system to target myeloma. In what the charity describes as a “world first”, the Phase Ib study, called MUK eleven, will investigate Oncolytics Biotech’ … |
|
Electroacupuncture releases stem cells to relieve pain, promote tissue repair, study finds
Medical Xpress Their findings, published online March 16 in the journal Stem Cells, provide the most comprehensive picture yet of how electroacupuncture stimulates the brain to facilitate the release of stem cells and adds new insight relating to the cells’ healing … |
Scot Scoop News |
CRISPR research promises to save lives
Scot Scoop News Haurwitz said, “CRISPR refers to a piece of DNA that’s found in a whole bunch of bacterial genomes. Basically, it’s this pattern of one sequence, repeated over and over, and in between are different sequences that are non-repetitive, called spacers.”. |
The Augusta Chronicle |
Nobel Prize winner discusses gene therapy at AU
The Augusta Chronicle A natural system for silencing genes that appears to be a way the body’s genetic material defends itself from unwanted changes is helping develop resistant crops but has not yet translated into many clinical therapies, said a 2006 Nobel Prize for … |